This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Meta-Analysis

. 2022 Mar;108(3):264-267.

doi: 10.1111/ejh.13729. Epub 2021 Dec 13.

mRNA COVID-19 vaccines in patients with chronic lymphocytic leukemia: A systematic review and meta-analysis

Stefano Molica¹, Diana Giannarelli², Emili Montserrat³

Affiliations

Affiliations

¹ Department Hematology-Oncology, Azienda Ospedaliera Pugliese-Ciaccio, Catanzaro, Italy.
² Biostatistic Unit, IRCCS Regina Elena, Rome, Italy.
³ Department of Hematology, Hospital Clinic, University of Barcelona, Barcelona, Spain.

PMID: 34856031
DOI: 10.1111/ejh.13729

Meta-Analysis

mRNA COVID-19 vaccines in patients with chronic lymphocytic leukemia: A systematic review and meta-analysis

Stefano Molica et al. Eur J Haematol. 2022 Mar.

. 2022 Mar;108(3):264-267.

doi: 10.1111/ejh.13729. Epub 2021 Dec 13.

Authors

Stefano Molica¹, Diana Giannarelli², Emili Montserrat³

Affiliations

¹ Department Hematology-Oncology, Azienda Ospedaliera Pugliese-Ciaccio, Catanzaro, Italy.
² Biostatistic Unit, IRCCS Regina Elena, Rome, Italy.
³ Department of Hematology, Hospital Clinic, University of Barcelona, Barcelona, Spain.

PMID: 34856031
DOI: 10.1111/ejh.13729

No abstract available

Keywords: chronic lymphocytic leukemia; mRNA SARS-CoV-2 vaccine; meta-analysis; systematic review; treatment status.

PubMed Disclaimer

Similar articles

COVID-19 vaccination: Evaluation of risk for protection failure in chronic lymphocytic leukemia patients.
Del Poeta G, Bomben R, Polesel J, Rossi FM, Pozzo F, Zaina E, Cattarossi I, Varaschin P, Nanni P, Boschian Boschin R, Postorino M, Laureana R, Pasqualone G, Steffan A, Gentile M, Zucchetto A, Gattei V. Del Poeta G, et al. Hematol Oncol. 2021 Dec;39(5):712-714. doi: 10.1002/hon.2916. Epub 2021 Aug 30. Hematol Oncol. 2021. PMID: 34462939 Free PMC article. No abstract available.
The mRNA COVID-19 vaccine in patients with cancer receiving checkpoint inhibitor therapy: what we know and what we don't.
Malek AE, Cornejo PP, Daoud N, Alam M. Malek AE, et al. Immunotherapy. 2022 Feb;14(2):91-94. doi: 10.2217/imt-2021-0235. Epub 2021 Nov 8. Immunotherapy. 2022. PMID: 34747190 Free PMC article. No abstract available.
Three, four or more: what's the magic number for booster shots?
Watson C. Watson C. Nature. 2022 Feb;602(7895):17-18. doi: 10.1038/d41586-022-00200-9. Nature. 2022. PMID: 35091715 No abstract available.
Reasons and consequences of COVID-19 vaccine failure in patients with chronic lymphocytic leukemia.
Morawska M. Morawska M. Eur J Haematol. 2022 Feb;108(2):91-98. doi: 10.1111/ejh.13722. Epub 2021 Dec 5. Eur J Haematol. 2022. PMID: 34717004 Free PMC article. Review.
Systematic Review: Safety and Efficacy of mRNA COVID-19 Vaccines in Pregnant Women.
Lam JN, Nehira J, Phung O, Deng B. Lam JN, et al. J Pharm Pract. 2024 Aug;37(4):967-976. doi: 10.1177/08971900231196065. Epub 2023 Aug 22. J Pharm Pract. 2024. PMID: 37605626

See all similar articles

Cited by

Current perspectives regarding SARS-CoV-2 vaccination in chronic lymphocytic leukemia.
Molica S, Tam C, Polliack A. Molica S, et al. Hematol Oncol. 2022 Aug;40(3):313-319. doi: 10.1002/hon.2990. Epub 2022 Mar 23. Hematol Oncol. 2022. PMID: 35304771 Free PMC article.
Vaccine challenges in CLL: a comprehensive exploration of efficacy of SARS-CoV-2 immunization for patients with chronic lymphocytic leukemia.
Kontandreopoulou CN, Solomou EE, Kolorizos E, Diamantopoulos PT. Kontandreopoulou CN, et al. Ann Hematol. 2024 Dec;103(12):4971-4980. doi: 10.1007/s00277-024-05869-8. Epub 2024 Jul 15. Ann Hematol. 2024. PMID: 39008060
COVID-19 vaccine response and safety in patients with cancer: An overview of systematic reviews.
Sun H, Bu F, Li L, Zhang X, Yan J, Huang T. Sun H, et al. Front Public Health. 2022 Nov 15;10:1072137. doi: 10.3389/fpubh.2022.1072137. eCollection 2022. Front Public Health. 2022. PMID: 36457318 Free PMC article.
A systematic review and meta-analysis of immune response against first and second doses of SARS-CoV-2 vaccines in adult patients with hematological malignancies.
Noori M, Azizi S, Abbasi Varaki F, Nejadghaderi SA, Bashash D. Noori M, et al. Int Immunopharmacol. 2022 Sep;110:109046. doi: 10.1016/j.intimp.2022.109046. Epub 2022 Jul 12. Int Immunopharmacol. 2022. PMID: 35843148 Free PMC article.
COVID-19 in Patients with Chronic Lymphocytic Leukemia: What Have We Learned?
Harel R, Itchaki G. Harel R, et al. Acta Haematol. 2024;147(1):60-72. doi: 10.1159/000534540. Epub 2023 Oct 11. Acta Haematol. 2024. PMID: 37820599 Free PMC article. Review.

See all "Cited by" articles

References

REFERENCES

1. Molica S, Giannarelli D, Lentini M et al. A clue to better select chronic lymphocytic leukemia patients with optimal response to BNT162b2 mRNA COVID-19 vaccine. Paper presented at 63rd ASH Annual Meeting and Exposition; December 11-14, 2021; Atlanta, GA, Abstract 3740.
1. Creech CB, Walker SC, Samuels RJ. SARS-CoV-2 vaccines. JAMA. 2021;325(13):1318-1320.
1. Griffiths EA, Segal BH. Immune responses to COVID-19 vaccines in patients with cancer: promising results and a note of caution. Cancer Cell. 2021;39:1045-1047.
1. Herishanu Y, Avivi I, Aharon A, et al. Efficacy of the BNT162b2 mRNA COVID-19 vaccine in patients with chronic lymphocytic leukemia. Blood. 2021;137(23):3165-3173.
1. Forconi F, Moss P. Perturbation of the normal immune system in patients with CLL. Blood. 126(5):573-581.

Publication types

Actions
Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Wiley
Medical
- MedlinePlus Health Information
Miscellaneous
- NCI CPTAC Assay Portal